Overview
Status
Active
Registry date
2016-06-30
Share capital
1,100,000.00 PLN
Registered address
ul. Żelazna 1, 40-851 Katowice, Poland
Electronic delivery address
AE:PL-38295-58213-SWFSH-20
Financials
Revenue history (in k)
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 70 days for 2021).
- 202512/08/2026
- 202426/06/2025
- 202309/07/2024
- 202223/06/2023
- 202123/09/2022
- 202023/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Division · Manufacture of basic pharmaceutical products and pharmaceutical preparations161 / 231
Top 70%
Results vs industry
Revenue
This companyUSD 166.15kMedianUSD 919.05kAverageUSD 25.83m
Net profit
This companyUSD -6.94kMedianUSD 14.92kAverageUSD 2.77m
Operating costs
This companyUSD 172.92kMedianUSD 873.06kAverageUSD 21.43m
Assets
This companyUSD 53.51kMedianUSD 897.46kAverageUSD 31.52m
Industry
- Manufacture of other food products (10.8)
Trademarks
Ferti Pharm currently holds no active trademarks with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2016.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| PREGNEA(word) | Z.474336 | 5 | Proceedings discontinued | – | |
| FERTINEA | Z.459107 | 5 | Expired | – |
| Mark | Protected until | |
|---|---|---|
| PREGNEA(word) | – | |
| FERTINEA | – |
Authorized Representatives
Anna Bednarska Czerwińska – Management Board Member
Paweł Czerwiński – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations and represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 11,000 | $297,136.68 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2016-09-07.
72 1050 1214 1000 0090 3096 3913- 49 1050 1214 1000 0090 3096 3939
- 50 1050 1214 1000 0090 3096 3921
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 7, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Katowice |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| STEM Cells SpinS.A. | $287,714.76 | stemcellsspin.com.pl | ||
| F1 PharmaS.A. | $272,113.66 | f1pharma.pl | ||
| Ti-Comsp. z o.o. | $157,549.77 | ticomglobal.com | ||
| LideoS.A. | $95,067.91 | lideo.tech | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| BIO Animalisp. z o.o. | $49,176.96 | proanimali.com | ||
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl | ||
| Xenira Pharmaceuticalssp. z o.o. | $26,670.82 | xenirapharma.com | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl |
Change history
| Date | Event | |
|---|---|---|
| 2020-09-18 | Share capital increase (5,000.00 PLN → 1,100,000.00 PLN) | |
| 2016-06-30 | Entered in the register |
FAQ
Last updated: 2026-10-07